Preoperative combined radiochemo-moleculartargettherapy of the locally advanced rectum carcinoma (cT3NxM0) - a phase II pilot study with preoperative application of capecitabine, bevacizumab and radiotherapy (RTx)
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Bevacizumab; Capecitabine
- Indications Colorectal cancer
- Focus Adverse reactions
- 12 Mar 2009 Actual initiation date changed from May 2008 to Jul 2008 as reported by ClinicalTrials.gov.
- 12 Mar 2009 Actual patient number (8) added as reported by ClinicalTrials.gov.
- 12 Mar 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.